Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST).

Abraham WT, Compton S, Haas G, Foreman B, Canby RC, Fishel R, McRae S, Toledo GB, Sarkar S, Hettrick DA; FAST Study Investigators..

Congest Heart Fail. 2011 Mar-Apr;17(2):51-5. doi: 10.1111/j.1751-7133.2011.00220.x.

2.

Improved algorithm to detect fluid accumulation via intrathoracic impedance monitoring in heart failure patients with implantable devices.

Sarkar S, Hettrick DA, Koehler J, Rogers T, Grinberg Y, Yu CM, Abraham WT, Small R, Tang WH.

J Card Fail. 2011 Jul;17(7):569-76. doi: 10.1016/j.cardfail.2011.03.002.

PMID:
21703529
3.
4.

Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.

Small RS, Wickemeyer W, Germany R, Hoppe B, Andrulli J, Brady PA, Labeau M, Koehler J, Sarkar S, Hettrick DA, Tang WH.

J Card Fail. 2009 Aug;15(6):475-81. doi: 10.1016/j.cardfail.2009.01.012.

PMID:
19643357
5.

Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial.

Conraads VM, Tavazzi L, Santini M, Oliva F, Gerritse B, Yu CM, Cowie MR.

Eur Heart J. 2011 Sep;32(18):2266-73. doi: 10.1093/eurheartj/ehr050.

PMID:
21362703
6.

Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization.

Yu CM, Wang L, Chau E, Chan RH, Kong SL, Tang MO, Christensen J, Stadler RW, Lau CP.

Circulation. 2005 Aug 9;112(6):841-8.

7.

Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.

Vanderheyden M, Houben R, Verstreken S, Ståhlberg M, Reiters P, Kessels R, Braunschweig F.

Circ Heart Fail. 2010 May;3(3):370-7. doi: 10.1161/CIRCHEARTFAILURE.109.867549.

8.

Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure.

Vollmann D, Nägele H, Schauerte P, Wiegand U, Butter C, Zanotto G, Quesada A, Guthmann A, Hill MR, Lamp B; European InSync Sentry Observational Study Investigators..

Eur Heart J. 2007 Aug;28(15):1835-40.

PMID:
17309902
9.

Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure.

Catanzariti D, Lunati M, Landolina M, Zanotto G, Lonardi G, Iacopino S, Oliva F, Perego GB, Varbaro A, Denaro A, Valsecchi S, Vergara G; Italian Clinical Service Optivol-CRT Group..

Pacing Clin Electrophysiol. 2009 Mar;32(3):363-70. doi: 10.1111/j.1540-8159.2008.02245.x.

PMID:
19272067
10.

A critical link between heart failure self-care and intrathoracic impedance.

Rathman LD, Lee CS, Sarkar S, Small RS.

J Cardiovasc Nurs. 2011 Jul-Aug;26(4):E20-6. doi: 10.1097/JCN.0b013e3181ee28c8.

PMID:
21076309
11.

Intrathoracic impedance and pulmonary wedge pressure for the detection of heart failure deterioration.

Maines M, Catanzariti D, Cirrincione C, Valsecchi S, Comisso J, Vergara G.

Europace. 2010 May;12(5):680-5. doi: 10.1093/europace/eup419.

PMID:
20047927
12.

Analysis of different device-based intrathoracic impedance vectors for detection of heart failure events (from the Detect Fluid Early from Intrathoracic Impedance Monitoring study).

Heist EK, Herre JM, Binkley PF, Van Bakel AB, Porterfield JG, Porterfield LM, Qu F, Turkel M, Pavri BB; DEFEAT-PE Study Investigators..

Am J Cardiol. 2014 Oct 15;114(8):1249-56. doi: 10.1016/j.amjcard.2014.07.048.

PMID:
25150135
13.
14.

Intrathoracic impedance monitoring to predict decompensated heart failure.

Ypenburg C, Bax JJ, van der Wall EE, Schalij MJ, van Erven L.

Am J Cardiol. 2007 Feb 15;99(4):554-7.

PMID:
17293202
15.

Predictive impact of the decreasing rate of intrathoracic impedance in worsening chronic heart failure.

Yamada S, Suzuki H, Kamiyama Y, Saitoh S, Takeishi Y.

J Interv Card Electrophysiol. 2014 Jun;40(1):87-91. doi: 10.1007/s10840-014-9881-3.

PMID:
24652550
16.

Efficacy of fluid assessment based on intrathoracic impedance monitoring in patients with systolic heart failure.

Soga Y, Ando K, Arita T, Hyodo M, Goya M, Iwabuchi M, Nobuyoshi M.

Circ J. 2011;75(1):129-34.

17.

Uncovering interim clinical events at the time of clinical encounter by reviewing intrathoracic impedance threshold crossings.

Tang WH, Wickemeyer WJ, Germany RE, Hoppe BL, Andriulli JA, Brady PA, Sarkar S, Hettrick DA, Small RS.

J Card Fail. 2011 Nov;17(11):893-8. doi: 10.1016/j.cardfail.2011.07.005.

PMID:
22041325
18.
19.

Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization.

Perego GB, Landolina M, Vergara G, Lunati M, Zanotto G, Pappone A, Lonardi G, Speca G, Iacopino S, Varbaro A, Sarkar S, Hettrick DA, Denaro A; Optivol-CRT Clinical Service Observational Group..

J Interv Card Electrophysiol. 2008 Dec;23(3):235-42. doi: 10.1007/s10840-008-9303-5.

PMID:
18810621
20.

Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.

van Veldhuisen DJ, Braunschweig F, Conraads V, Ford I, Cowie MR, Jondeau G, Kautzner J, Aguilera RM, Lunati M, Yu CM, Gerritse B, Borggrefe M; DOT-HF Investigators..

Circulation. 2011 Oct 18;124(16):1719-26. doi: 10.1161/CIRCULATIONAHA.111.043042.

Items per page

Supplemental Content

Support Center